Pu*Ac reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information , 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
REPORT DATE (DD-MM-YYYY)2. REPORT Se. TASK NUMBER 5f. WORK UNIT NUMBER E-Mail: jianzhan@iupui.edu
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT
NUMBERIndiana University Indianapolis, IN 46202-5167
SPONSORING I MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSORJMONITOR'S ACRONYM(S)U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSORIMONITOR'S REPORT NUMBER(S)
DISTRIBUTION I AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited.
SUPPLEMENTARY NOTES
ABSTRACTIn this project, we proposed to use a dicistronic expression system to determine whether the long 5'-UTR sequence of PTEN contains internal ribosome entry site (IRES) which can mediate cap-independent translation. We have accomplished the proposed work as planed.However, we found that the long 5'-UTR sequence of PTEN does not have the predicted IRES activity but rather contains a strong promoter. We have mapped this promoter and it is likely responsible for constitutive production of the PTEN mRNAs with shorter 5'-UTRs in prostate cancer cells which would be compatible for cap-dependent translation initiation.We have also created a promoterless dicistronic vector and validated its use as a more stringent assay for testing cellular IRES activities. 'INTRODUCTION PTEN/MMAC1/TEPI (referred as PTEN in the remaining text of this paper) is a tumor suppressor gene that maps to the 1 0q23.3 and has been shown to be deleted or mutated in many human tumors including glioblastomas, endometrial neoplasms, hematological malignancies, and prostate and breast cancers (Ali et al., 1999;Cantley and Neel, 1999;Dahia, 2000;Di Cristofano and Pandolfi, 2000). In addition, germline mutations in PTEN cause Cowden syndrome (CS), characterized by multiple hamartomas and a high proclivity for developing cancer (Cantley and Neel, 1999). The 5'-UTRs of human and mouse PTEN are highly homologous (the 0.9 kb 5'-UTR near the translation start codon shows -90% homology) and have many features of a translationally-regulated gene. Firstly, they are significantly longer (>0.95 kb) than the average eukaryotic 5'-UTR. Secondly, they conta...